Publications

Sonneveld N, Jackson J, Dey A, Lambert SB, Beard FH. Varicella-zoster-virus-related hospital episodes increasingly coded concurrently for varicella and zoster, Australia, 2002-2021. Health Information Management 2025:18333583251364580. doi: 10.1177/18333583251364580 (Epub). [Abstract]

Koirala AH, Prasad SA, Britton PN, Wood NO, Richmond PC, McMullan BN, Crawford NW, Marshall HS, Francis LU, Wills ME, Leighton EM, Macartney K, Bolsewicz KR. Understanding motivation and experience in participating in a paediatric SARS-CoV-2 serosurvey, in Australia. Vaccine: X 2025;27:100716. doi: 10.1016/j.jvacx.2025.100716 (Epub). [Full text]

Liu B, Scaria A, Stepien S, Macartney K. Effectiveness of COVID-19 vaccine boosters for reducing COVID-19 mortality among people aged 65 years or older, Australia, August 2023 - February 2024: a retrospective observational cohort study . Medical Journal of Australia 2025. doi: 10.5694/mja2.70015 (Epub). [Full text]

Pennington K, Jayasinghe S, Gorrell L. Invasive pneumococcal disease in Australia: 2013 and 2014. Communicable Disease Intelligence (2018) 2025;49. doi: 10.33321/cdi.2025.49.038. [Abstract]

Misan A, Lambert SB, Phung H, Young MK. Evaluation of the Queensland JEV vaccine program response to the 2022 Australian outbreak - CORRIGENDUM. Epidemiology and Infection 2025;153:e14. doi: 10.1017/S0950268825000019. Erratum for: doi:10.1017/S0950268824001730. [Full text]

Shrestha S, Bijukchhe SM, Wahl B, Carter MJ, Kandasamy R, Gurung M, O'Reilly PJ, Voice M, Pokhrel B, Amatya P, Bhandari S, Shrestha S, Kelly S, Kelly DF, Thorson S, Murdoch DR, Fink C, Deloria Knoll M, Pollard AJ. Respiratory viral detection in children hospitalized with pneumonia during periods of major population disruptions in Nepal, 2014-2018. Journal of the Pediatric Infectious Diseases Society 2025;14:piaf052. doi: 10.1093/jpids/piaf052. [Full text]

Paynter J, McIntyre P, Wiki J, Nghiem N, Liu B, Marek L, Hobbs M. Using nationwide data to examine the relative effectiveness of Covid-19 vaccination against omicron amongst a population with low prior rates of SARS-CoV-2 infection: a cohort study. Vaccine:X 2025;24:100624. doi: 10.1016/j.jvacx.2025.100624 . [Full text]

Christou-Ergos M, Sabahelzain MM, Steffens M, Kaufman J, Bolsewicz KT, Danchin M, Leask J. The drivers of influenza vaccination in adults: insights from a national Australian survey. Vaccine:X 2025;25:100683. doi: 10.1016/j.jvacx.2025.100683. [Full text]

McAlister SM, Dierig A, van den Biggelaar AH, Thornton R, Cooper MN, McIntyre P, Richmond PC, Wood N. Immunogenicity and safety of a 2 + 1 DTPa priming schedule in Australian infants and the impact of maternally derived antibodies on pertussis antibody responses up to 4 years of age. Journal of the Pediatric Infectious Diseases Society 2025;14:piaf067. doi: 10.1093/jpids/piaf067. [Abstract]

Jayasinghe S, Williams PC, Macartney KK, Crawford NW, Blyth CC. Assessing the impact of pneumococcal conjugate vaccine immunization schedule change from 3+0 to 2+1 in Australian children: a retrospective observational study. Clinical Infectious Diseases 2025;80:207-214. doi: 10.1093/cid/ciae377. [Full text]